Plenary sessions/joint sessions

11:15–12:45 hrs.
Neurosurgical Oncology

Learning from the Past – Pitfalls in Studies on Glioblastomas
Roger Stupp (Chicago, IL/US)

Low Grade Gliomas – Current Changes of Strategy
Ole Solheim (Trondheim/Norway)

Epidemiological Aspects of Schwannomas and the Implications for the Neurosurgeon
Tiit Illimar Mathiesen (Copenhagen/Denmark)

Quo Vadis Neurosurgical Oncology?
Jörg-Christian Tonn (Munich/Germany)

16:15–17:15 hrs.
Spinal Neurosurgery (in cooperation with the German Spine Society)

Evidence Based Decision Making to Meet the Increased Need of Treatment for Lumbar Spinal Stenosis
Peter Försth (Uppsala/Sweden)

Complications in Adult Spine Deformity Surgery
Ulf Liljenqvist (Münster/Germany)

Spinal Surgery 2030 – Minimally Invasive Techniques, Navigation, Robotics and More
Claudius Thomé (Innsbruck/Austria)

10:30–12:00 hrs.
Neuromodulation/Skull Base Surgery

Quality of Life in Vestibular Schwannomas – the Neurosurgeon’s Perspective
Erling Myrseth (Bergen/Norway)

Preservation or Rehabilitation of Auditory Function in Infiltrative Schwannomas?
Stefan Plontke (Halle, Saale/Germany)

Neuromodulation in Neurodegenerative Disease – State of the Art and Perspectives
Andres Lozano (Toronto, ON/Canada)

Neurodegenerative Disease – Challenges from the Neurological Perspective
Jens Volkmann (Würzburg/Germany)

16:00–17:00 hrs.
Neurotraumatology

Novel Techniques in the Understanding and Treatment of Traumatic Brain Injury Patients
Niklas Marklund (Lund/Sweden)

Chronic Subdural Haematoma in the Elderly – a Growing Challenge for Neurosurgery and the Health Care System
Magnus Olivecrona (Örebro/Sweden)

Traumatic Brain Injury – Provision of Care, Registers, Trials and More
Andreas Unterberg (Heidelberg/Germany)

09:15–10:15 hrs.
Paediatric Neurosurgery

What is the Outlook for a Hydrocephalic Child?
Magnus Tisell (Gothenburg/Sweden)

Future Aspects in Craniofacial Treatment Strategies
Tilmann Schweitzer (Würzburg/Germany)

12:00–13:00 hrs.
Neurovascular Diseases (in cooperation with the European Association of Neurosurgical Societies)

Biology Based Personalised Medicine for Vascular Neurosurgery – Lessons Learned from Translational Aneurysm and AVM Research
Juhana Frösen (Kuopio/Finland)

Translational Neuroscience and Neurovascular Units – a Scenario for 2030
Daniel Hänggi (Mannheim/Germany)

2030 – the Near Future of Neuroendovascular Therapy
Mirko Pham (Würzburg/Germany)